FDA Clears Encora X1 Wrist-Worn Device for Essential Tremor
The Encora X1 is a noninvasive, wrist-worn neurostimulation device designed to reduce hand tremors and improve daily function in adults with essential tremor.
The Encora X1 is a noninvasive, wrist-worn neurostimulation device designed to reduce hand tremors and improve daily function in adults with essential tremor.
A new study projects that global ALS prevalence will rise by about 25% by 2040—driven largely by an aging population and improved survival.
Women with traumatic brain injuries face unique challenges in recovery due to hormonal, anatomical, and social factors that differ from those affecting men, necessitating more tailored medical approaches.
CurePSP awarded CARES grants to support collaborative, multi-center projects aimed at improving care, access, and education for patients with PSP, CBD, and MSA.
Read MoreHelius Medical Technologies Inc. has surpassed initial enrollment targets for its stroke registrational program evaluating PoNS Therapy, a novel neuromodulation approach to improve gait and balance in stroke patients.
Read MoreHigh-frequency spinal cord stimulation effectively reduces muscle spasticity in patients with incomplete spinal cord injuries, enabling better rehabilitation outcomes.
Read MoreResearchers reveal the impact of neurophysiological interventions such as somatosensory electrical wrist stimulation on influencing hand-choice decision in stroke rehab.
Read MoreA research team at Case Western Reserve University is pioneering a novel approach to multiple sclerosis (MS) treatment by targeting toxic astrocytes, with the goal of protecting and regenerating nerve cells.
Read MoreInnovations in rehabilitation techniques—from telehealth to advanced neurotechnology—are enhancing recovery outcomes for stroke survivors.
Read MoreA large-scale study of military veterans suggests a possible link between hearing loss and increased risk of Parkinson’s disease.
Read MoreUCI researchers’ discovery about ophthalmic acid offers new therapeutic potential for Parkinson’s and other movement disorders.
Read MoreIn people with primary progressive multiple sclerosis (MS), a new study compared the amount of time before disability worsened between people receiving certain MS therapies and those not receiving treatment.
Read MoreAI is on the verge of true breakthroughs in the diagnosis, prognosis, and treatment of neurological disorders, including Parkinson’s and stroke.
Read MoreScientists developed an immunotherapy to minimize the damage from traumatic spinal cord injury, instead of repairing damaged tissue.
Read MoreGood Shepherd Rehabilitation is the first clinical user in the U.S. to use the robotic exoskeleton to help people with stroke and spinal cord injury to walk.
Read MoreContrary to previous research, a new study of female participants finds no link between migraine and the risk of developing Parkinson’s.
Read MoreStudy findings could have implications for treating or preventing the muscle wasting sometimes associated with inflammatory diseases, including Alzheimer’s disease and long COVID.
Read MorePeople with higher levels of metals found in their blood and urine may be more likely to be diagnosed with—and die from—ALS, a new study suggests.
Read More